Skip to main content
. 2020 Jul 14;5(Suppl 3):e000852. doi: 10.1136/esmoopen-2020-000852

Figure 2.

Figure 2

Preferred treatment choice in fit and unfit, IMDC intermediate/poor-risk patients outside and during the COVID-19 pandemic. IMDC, International Metastatic Renal Cell Carcinoma Database Consortium.